Zhejiang Orient Gene Biotech

Zhejiang Orient Gene Biotech is a leading global developer and manufacturer of in vitro diagnostic (IVD) products, specializing in rapid testing solutions. The company offers an extensive portfolio of point-of-care testing (POCT) kits covering infectious diseases, drugs of abuse, oncology markers, and cardiac health. Orient Gene gained significant international prominence during the COVID-19 pandemic as a major supplier of rapid antigen tests, often serving as an OEM partner for large multinational healthcare corporations. Their core technology platforms include colloidal gold, fluorescence immunoassay, and molecular diagnostics. Headquartered in Anji, China, the company maintains a strong global footprint with significant export operations to over 120 countries and a major US presence through its subsidiary, Healgen Scientific.